ACCOuNT is focused on reducing health disparities, in particular among African Americans, through pharmacogenomics research.
The resources below provide additional information for patients and providers on health disparities, pharmacogenomics, and precision medicine. Resources are arranged by topic and target audience. Click each bullet to reveal more information.
General information on health disparitiesNational Institute on Minority Health and Health Disparities (NIMHD)
Other TCCs that are funded through NIMHD and focus on precision medicine and health disparities are listed below.
- Meharry-Vanderbilt Center of Excellence in Precision Medicine: This TCC uses precision medicine research to eradicate health disparities, specifically those among African Americans and Latinos.
- Stanford Precision Health for Ethnic and Racial Equity (SPHERE) Transdisciplinary Collaborative Center: This TCC focuses on using precision medicine tools to improve the health of underserved ethnic and racial groups.
- Yale Transdisciplinary Collaborative Center for Health Disparities Research focused on Precision Medicine: This TCC collaborates with the Equity Research and Innovation Center (ERIC) to reduce the burden of non-communicable diseases within New York, New Jersey, and the Caribbean.
Nationwide pharmacogenomics research studiesAll of Us Study
The All of Us Research Program is a historic effort to gather data from one million or more people living in the United States to accelerate research and improve health. By taking into account individual differences in lifestyle, environment, and biology, researchers will uncover paths toward delivering precision medicine. Enroll here.
Implementing pharmacogenomics in practiceFDA: Table of Pharmacogenomic Biomarkers in Drug Labeling
View a listing of FDA-approved drugs with pharmacogenomic information in their labeling.
PGRN resources include:
- Clinical Pharmacogenetics Implementation Consortium: The CPIC provides guidelines that enable the translation of genetic laboratory test results into actionable prescribing decisions for specific drugs.
- PharmGKB: The Pharmacogenomics Knowledgebase: PharmGKB collects, curates, and disseminates information on the impact of human genetic variation.
Other resourcesThe NIH Precision Medicine Initiative (PMI) Cohort Program
Started by President Obama in 2015, PMI is a research effort focused on gathering data from one million or more people living in the United States to accelerate research and improve health through precision medicine. Learn more.
Below are some research programs that are a part of the PMI:
- NIH All of Us Research Program: In 2016, the PMI Cohort Program was renamed to the All of Us Research Program, which is getting ready to begin data collection.
- The Illinois Precision Medicine Consortium: Helping to lead the PMI in Chicago, the Consortium is comprised of a group of health care provider organizations led by Northwestern University, University of Chicago, University of Illinois at Chicago, Ann & Robert H. Lurie Children’s Hospital and the Alliance of Chicago Community Health Services, LLC.
Disclaimer: The ACCOuNT website provides links to other internet sites for informational purposes and the convenience of its users. The ACCOuNT team does not endorse or recommend any specific organizations, resources, or products.